Molecular Energies PLC Director Share Purchase
02 Avril 2024 - 4:02PM
RNS Regulatory News
RNS Number : 0141J
Molecular Energies PLC
02 April 2024
2 April
2024
THIS ANNOUNCEMENT CONTAINS INSIDE
INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU NO.
596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE
EUROPEAN UNION (WITHDRAWAL) ACT 2018 (AS AMENDED) ("MAR"). UPON THE
PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION
SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE
PUBLIC DOMAIN.
MOLECULAR ENERGIES
PLC
("Molecular" or the "Company")
Director Share
Purchase
Molecular Energies plc (AIM:
MEN), the international energy company, announces it has today been informed that on 2 April
2024, PLLG Investments
Limited, a company wholly beneficially
owned by Peter Levine, Chairman and largest shareholder in the
Company, acquired 262,000 ordinary shares in the capital of the
Company ("Ordinary Shares") at a price of 7p per Ordinary Share
(the "Share Purchase"). This reflects the statement made by Peter
Levine in the Company's announcement of 28 March 2024 (the
"Announcement") that he has "conviction in the value of
Molecular as a whole" as a private
enterprise and notwithstanding the proposed cancellation of the
admission of the Ordinary Shares to trading on the AIM Market of
the London Stock Exchange. Peter Levine reiterates the statement
made in the Announcement that he "invite[s] any shareholders
so minded to continue the journey alongside"
but that "whilst making no commitment to do so, I do not rule out in the
fullness of time and subject to de-listing and on becoming a
private company making proposals to buy the shares of certain of
those holders who either do not wish or are unable to be invested
in a private business".
Peter Levine is currently restricted from
acquiring further Ordinary Shares without making a logistically
burdensome general offer to all other shareholders since the
Takeover Code continues to apply to the Company.
Following the Share Purchase, Peter
Levine has a beneficial interest in 3,269,267 Ordinary Shares
representing 26.41 per cent. of the issued share capital. Peter
Levine and those acting in concert with him have combined
beneficial interest in 3,705,981 Ordinary Shares representing 29.94
per cent. of the issued share capital.
Molecular Energies PLC
Peter Levine, Chairman
Rob Shepherd, Group FD
|
+44 (0)20 7016 7950
info@molecularenergiesplc.com
|
Cavendish Capital Markets Limited
(Nominated Adviser & Broker)
Simon Hicks
George Dollemore
|
+44 (0)20 7220 0500
|
Tavistock (Financial PR &
IR)
Simon Hudson, Nick Elwes, Saskia
Sizen
|
+44 (0)20 7920 3150
|
For the purposes of MAR, Article 2
of Commission Implementing Regulation (EU) 2016/1055 and the UK
version of such implementing regulation (as amended), the
person responsible for arranging for the release of this
Announcement on behalf of the Company is Peter Levine,
Chairman.
Pursuant to the notification obligations in accordance with
Article 19 of the Market Abuse Regulation (MAR)
1.
|
Details of PDMR / person closely associated with them
('PCA')
|
a)
|
Name
|
Peter Levine through PLLG Investments
Limited
|
2.
|
Details of PDMR / person closely associated with them
('PCA')
|
a)
|
Position / status
|
Chairman
|
b)
|
Initial notification /
amendment
|
Initial notification
|
3.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
a)
|
Name
|
Molecular Energies plc
|
b)
|
LEI
|
213800MA2ZN22I4ITA79
|
4.
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument;
(ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
c)
|
Description of the financial
instrument
|
Ordinary shares of
1p each
ISIN: GB00B3DDP128
|
d)
|
Nature of the transaction
|
Purchase of Ordinary
Shares
|
e)
|
Price and volume
|
|
Price (PENCE)
|
Volume
|
Peter Levine
|
7p
|
262,000
|
|
f)
|
Aggregated information
Aggregated volume
Price
|
262,000 Ordinary Shares at 7p per Ordinary Share
|
g)
|
Date of the transaction
|
2 April 2024
|
h)
|
Place of the transaction
|
London Stock
Exchange, AIM (XLON)
|
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
DSHUURSRSRUSRAR
Molecular Energies (LSE:MEN)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024
Molecular Energies (LSE:MEN)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024